Abstract
Natural products are recent emerging effective agents against many chronic human diseases. Curcumin (diferuloylmethane), the active constituent of turmeric (Curcuma longa), has gained much interest as a plant-based compound with pleiotropic biological activities. Curcumin has been shown to possess significant anti-oxidant, anti-carcinogenic, anti-inflammatory, and anti-microbial effects. Although the history of curcumin goes back thousands of years, the mechanism involved behind medicinal role of curcumin remains a topic of debate. In addition to this, its stability, solubility and bioavailability issues create reasons for further researches on this yellow molecule. Present article provides an overview of the history, chemistry, biological effects, and an update of mechanism(s) of action of curcumin.
Keywords: Curcumin, antioxidant, biological activities, bioavailability.
Letters in Drug Design & Discovery
Title:Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Volume: 13 Issue: 2
Author(s): Prabhakar Singh, Kanti Bhooshan Pandey and Syed Ibrahim Rizvi
Affiliation:
Keywords: Curcumin, antioxidant, biological activities, bioavailability.
Abstract: Natural products are recent emerging effective agents against many chronic human diseases. Curcumin (diferuloylmethane), the active constituent of turmeric (Curcuma longa), has gained much interest as a plant-based compound with pleiotropic biological activities. Curcumin has been shown to possess significant anti-oxidant, anti-carcinogenic, anti-inflammatory, and anti-microbial effects. Although the history of curcumin goes back thousands of years, the mechanism involved behind medicinal role of curcumin remains a topic of debate. In addition to this, its stability, solubility and bioavailability issues create reasons for further researches on this yellow molecule. Present article provides an overview of the history, chemistry, biological effects, and an update of mechanism(s) of action of curcumin.
Export Options
About this article
Cite this article as:
Singh Prabhakar, Pandey Bhooshan Kanti and Rizvi Ibrahim Syed, Curcumin: the Yellow Molecule with Pleiotropic Biological Effects, Letters in Drug Design & Discovery 2016; 13 (2) . https://dx.doi.org/10.2174/1570180812666150630184101
DOI https://dx.doi.org/10.2174/1570180812666150630184101 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review
Current Drug Targets Alzheimer’s Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Current Alzheimer Research Gene Therapy for Osteoinduction
Current Gene Therapy Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Current Drug Metabolism Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Roles of Adrenomedullin in Hypertension and Hypertensive Organ Damage
Current Hypertension Reviews Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Current Neuropharmacology Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Cardiovascular & Hematological Disorders-Drug Targets Gene Therapy Strategies Towards Immune Tolerance to Treat the Autoimmune Diseases
Current Gene Therapy Cell Sources in Cardiac Tissue Engineering: Current Choices
Current Stem Cell Research & Therapy Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Current Pharmaceutical Design Metabolic Syndrome and Cardiometabolic Risk Factors
Current Vascular Pharmacology Adonis sp., Convallaria sp., Strophanthus sp., Thevetia sp., and Leonurus sp. - Cardiotonic Plants with Known Traditional Use and a Few Preclinical and Clinical Studies
Current Pharmaceutical Design Cardiovascular Imaging for Guiding Interventional Therapy in Structural Heart Diseases
Current Medical Imaging Editorial [Hot topic: MicroRNAs: from Basic Regulation Towards Therapeutic Approaches - Passion, Caution and Patience Required (Guest Editor: Dr. Thomas Thum)]
Current Drug Targets Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]
Current Pharmaceutical Design Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews Statins in Stroke
Current Medicinal Chemistry